Olfactory dysfunction, including parosmia, has been associated with liraglutide use 46 , likely reflecting GLP-1R-mediated modulation of odor-evoked insulin secretion and foraging behaviors in the olfactory bulb 51,52
They do not replace your daily routine
however, their clinical implementation remains suboptimal
GLP-1 receptor agonists slow gastric emptying , meaning food remains in the stomach longer, promoting feelings of fullness
For example, in an anabolic stack, administering a GH secretagogue to create a GH pulse, followed by IGF-1 LR3, can be strategic
Providers who offer injections to every patient without any lab work are operating on a wellness-mill model rather than a medically supervised one